Venrock Healthcare Capital Partners II, L.P. 4
4 · KalVista Pharmaceuticals, Inc. · Filed Mar 20, 2019
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2019-03-18$28.75/sh−500,000$14,375,000→ 1,544,112 total(indirect: By Funds)
Footnotes (2)
- [F1]Consists of (i) 408,110 shares held by Venrock Healthcare Capital Partners II, L.P. ("VHCP2"), (ii) 165,372 shares held by VHCP Co-Investment Holdings II, LLC ("VHCP Co-2"), (iii) 882,461 shares held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3") and (iv) 88,169 shares held by VHCP Co-Investment Holdings III, LLC ("VHCP Co-3").
- [F2]VHCP Management II, LLC ("VHCPM2") is the general partner of VHCP2 and the manager of VHCP Co-2 and may be deemed to beneficially own these shares. VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own these shares. Bong Koh and Nimish Shah are the managing members of VHCPM2 and VHCPM3 and may be deemed to beneficially own these shares. Each of VHCPM2, VHCPM3, Bong Koh and Nimish Shah expressly disclaim beneficial ownership over these shares except to the extent of their indirect pecuniary interests therein.